Benchmark raised its 12-month price target on Brunswick Corporation (NYSE: BC) to $90.00 from $75.00 on Friday, representing a 20% increase from the firm’s prior valuation, while leaving its Buy rating unchanged.
At the time of the note, Brunswick shares were trading at $79.22. Analyst target prices for the stock span a range from $68 to $115, according to InvestingPro data.
Benchmark’s upward revision followed Brunswick’s fourth-quarter 2025 financial report, which the research firm described as "broadly in line" with expectations. Benchmark noted that revenue exceeded its forecasts, operating income fell short of projections, and earnings per share were in line with estimates.
The company reported fourth-quarter earnings per share of $0.58, compared with an analyst forecast of $0.57, a 1.75% surprise. Revenue for the quarter came in at $1.33 billion versus the $1.21 billion analysts had anticipated, a 9.92% beat. Despite those results, Brunswick’s stock declined in pre-market trading following the announcement.
Benchmark observed that the shares had pulled back after the release, despite experiencing an approximate 40% gain since late November 2025. In its research note, the firm advised investors to "lean in on weakness," indicating it views the price drop as a potential buying opportunity.
The company’s earnings release and subsequent market reaction did not coincide with any reported merger or acquisition activity. Likewise, there were no recent analyst upgrades or downgrades reported for Brunswick in connection with these results.
These developments provide a current snapshot of Brunswick’s near-term outlook as assessed by Benchmark: a raised valuation predicated on revenue strength, tempered by operating income shortfalls and a market pullback immediately after the quarterly disclosure.